Skip to content
Ontario Rheumatology Association
  • Login
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory

OHIP+ Children and Youth Pharmacare Program

Denis Morrice • Edition: Summer 2017

Press Release from the Ministry of Health – July 6, 2017:

Minister’s Message:

Canadians have long cherished our universal, publicly funded health care system. It is a part of our national identity, rooted in the belief that all Canadians should have access to medical services, regardless of ability to pay.

Yet, while we are providing more patients with access to a health care provider, too often, we are failing them – particularly our most vulnerable – when it comes to prescription medications.  In order to achieve truly universal health care, we need to ensure they have access to the medications that they need.

Starting on January 1, 2018, Ontario is going to take a bold, historic step toward realizing this goal with the creation of OHIP+: Children and Youth Pharmacare Program.

OHIP+ will make Ontario the first province in Canada to provide universal, first dollar prescription drug coverage to everyone age 24 years and younger, regardless of their family income.  This program will benefit over 4 million children and youth, covering 100% of the cost of over 4,400 drug products – the entire Ontario Drug Benefit Formulary. There will be no annual deductible and no co-payments. All that’s needed is a valid prescription and an Ontario health card number.

Ontario is blazing a new path with this program, the most significant expansion of medicare in the province since its creation 50 years ago. I will continue to champion universal pharmacare, working to identify new opportunities to continue to expand prescription drug coverage for all Ontarians.

Honourable Eric Hoskins, Minister of Health and Long-Term Care

How will OHIP+: Children and Youth Pharmacare coverage work?

All children and youth aged 24 and under who have OHIP coverage will automatically be enrolled in OHIP+.   OHIP+ coverage will stop on an individual’s twenty-fifth birthday. The new OHIP+ program will cover all drugs and drug products currently reimbursed through the Ontario Drug Benefit (ODB) program. This includes more than 4,400 drug products listed on the ODB Formulary/Comparative Drug Index and additional drugs eligible for funding through the Exceptional Access Program (EAP).

This will include medications to treat:

  • asthma
  • depression
  • anxiety
  • attention deficit hyperactivity disorder (ADHD)
  • infections (e.g. antibiotics)
  • epilepsy
  • diabetes (including test strips)
  • reproductive health (e.g. oral contraceptives)
  • some childhood cancers and rare diseases

Starting January 1, 2018, if a child or youth aged 24 or under requires an eligible medication, they or their caregiver can bring their valid prescription and health card number to a pharmacy and will receive that medication at no cost.  Enrollment in OHIP+ will be automatic for children and youth with OHIP eligibility.  There will be no out of pocket costs (i.e. deductibles or co-payments).

What is not covered by OHIP+ Children and Youth Pharmacare:

Drug products that are not available through the ODB program will not be covered.

More Updates Coming

You can expect regular updates like this as we move forward together.

Please Stay in Touch

Visit us online at www.ontario.ca/OHIPplus

We value your feedback. If you have questions or comments, please email us at OHIPplus@ontario.ca

To automatically receive these updates, join our mailing list by emailing OHIPplus@ontario.ca

This document is available in alternate formats upon request.

Other Articles in the Summer 2017 Newsletter

  • 2017 ORA AGM & Resident's Weekend
  • General News Updates
  • OMA Section on Rheumatology Report
  • Informatics Update: Ensuring High Quality Care in Rheumatology by Leveraging Real World Data
Editions
  • Winter 2021
  • Fall 2020
  • Summer 2020
  • Winter 2020
  • Winter 2019
  • Fall 2019
  • Spring 2019
  • Winter 2018
  • Fall 2018
  • Summer 2018
  • Summer 2017
  • Spring 2017
  • Fall 2017
  • Archive
  • Meet the Speakers: ORA 20th Annual Scientific Meeting
Committees
Communications Informatics Models of Care OMA
Tags
Biosimilar CSDTH Models of Care OBRI OMA pCPA SADIE

Contributors

The ORA’s executive members are the core contributors to the newsletter. The ORA welcomes guest contributions to the newsletter from members-at-large and others in the rheumatology community.

Contributors
Ontario Rheumatology Association

© 2020 Ontario Rheumatology Association. All Rights Reserved. Website by Digital Chaos Inc.

  • About
  • Annual Awards
  • Events
  • EAP & Limited Use Codes
  • Exceptional Access Program
  • EAP Forms and Downloads
  • Limited Use Codes
  • Biosimilar Fact Sheet
  • NIHB Drug List
  • MOHLTC IVIG Request Form
  • Informatics
  • Members
  • Member Directory
  • Past Meeting Resources
  • Peer Mentor Forum
  • BecomeA Member
  • Renew Membership
  • News
  • Newsletters
  • Drug Shortages Info
  • Other Publications
  • Info Hub
  • Contact
  • Privacy